Clinical trial is music to cancer patient’s ears

Retired music educator is empowered – and cured – through clinical trial for triple negative breast cancer

Judith Ann BowserParticipating in a clinical trial helped retired high school chorus teacher Judy Bowser face the music when diagnosed with an aggressive type of breast cancer.

The decision may have saved her life.

“I wanted to leave no stone unturned, and a clinical trial was one more weapon we could use,” Judy said. “I jumped at the opportunity to enroll.”

Her cancer journey began in April 2008. Life was sweet: She was retired after 32 years as a music educator in school and church settings. She and her husband, Tom, reveled in being Opa and Granny to four young grandchildren. They were active in civic causes and traveled frequently from Olathe, Kansas, to a second home in Jackson Hole, Wyoming.

With no family history of breast cancer, Judy wasn’t overly concerned when she felt an odd lump on her ribcage, deep in her breast. “But when I saw my doctor’s face, I knew I had cancer,” Judy said. Extensive testing followed before she met with oncologist Priyanka Sharma, MD, at The University of Kansas Cancer Center.

Judy was diagnosed with triple negative breast cancer. Compared to other types of breast cancers, it grows faster, is more likely to recur within the first couple of years after treatment, and has a poorer prognosis. At stage II, Judy’s tumor was already about the size of her thumb.

Among the treatment options was a clinical trial Dr. Sharma was conducting. The Bowsers’ physician son Chris strongly urged Judy to enroll. “I told them ‘OK, I’m in. Let’s go,’ ” Judy remembered. “It really empowered me, to feel there was something I could do.”

The study was to determine if platinum chemotherapy – administered prior to surgery in combination with a targeted oral medication – was more effective than the standard therapy. At that time, Dr. Sharma led the only clinical trial in the country studying this combination in stage I-III patients.

Most commonly used breast cancer therapies target cell receptors for estrogen, progesterone and/or HER2. But triple negative breast cancer cells lack receptors for any of these three. Dr. Sharma is among leading researchers studying ways to improve treatment for this cancer, which accounts for about 15 percent of breast cancers.

“I remember thinking I was so fortunate to be at this cancer center, at this time, when this trial was open and I was eligible,” Judy said.

Instead of shrinking Judy’s tumor, the treatment eliminated it. A lumpectomy cleaned the site, and radiation treatments followed.

That was seven years ago.

“Judy’s cancer was completely eradicated with this chemotherapy regimen,” Dr. Sharma said. “She is now cured from this aggressive breast cancer.” Clinical trial results were encouraging, she added, as half the patients achieved complete or near complete response.

“I feel really good about participating,” Judy said. “Thousands of women before me were willing to be in clinical trials so better treatments would be available to me. I wanted to pay it forward.”

Writing new chapters with clinical trials

Thanks to clinical trials, patients like Judy Bowser are able to write their next chapter.

Clinical trials study new ways to prevent, detect or treat disease and are at the heart of all medical advances.

Eligible participants have the opportunity to receive the most promising new therapies and emerging treatment approaches not yet available to the general public. All standard medical treatments used today were once tested in clinical trials.

At The University of Kansas Cancer Center – the region’s only National Cancer Institute-designated Cancer Center – patients have access to more clinical trials than any other cancer center in the area. All trial participants receive leading-edge care from a specialized multidisciplinary care team.

To learn more, call 913-945-7552 or visit

Patients like Judy rely on us. Help us do more.

Click here to make a gift to support the future of academic medicine at The University of Kansas Hospital today.Our progress – and the progress of healthcare in our city and region – depends on the generosity of people like you. Because of such generosity, we're able to expand programs and treatments that save lives. And by giving, we can accelerate our ability to help those who need it most.

Be part of saving lives. Visit and learn more about the medical breakthroughs that happen here. 

Clinical Trials: Be Part of the Cure

Medical research finds ways to help people live longer, improve their quality of life and manage or cure disease. Participating in clinical trials may offer you access to promising therapies and will contribute to research that can improve care for future generations. Learn more.

This individual participated in a clinical trial of an investigational treatment. Clinical trials are different from standard medical care. As with all research studies, clinical trial participant outcomes vary. Before participating in a clinical trial, it is important to discuss the risks and benefits with your healthcare provider.

Expert Care

find a doctor

U.S. News and World Reports 2019-2020